Guangdong VTR Bio-Tech Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
1,106
- Stock Symbol
-
300381
- Investments
-
5
- Share Price
-
$0.79
- (As of Friday Closing)
Guangdong VTR Bio-Tech General Information
Description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme and others. It sells its products in China, and also exports it to various other countries.
Contact Information
Website
www.yiduoli.comCorporate Office
- No. 8 Pingbei Road 1
- Science and Technology Industry Zone Nanping
- Zhuhai, Guangdong 519060
- China
Corporate Office
- No. 8 Pingbei Road 1
- Science and Technology Industry Zone Nanping
- Zhuhai, Guangdong 519060
- China
Guangdong VTR Bio-Tech Stock Performance
As of 13-Nov-2026, Guangdong VTR Bio-Tech’s stock price is $0.79. Its current market cap is $377M with 480M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.79 | $0.80 | $0.74 - $1.13 | $377M | 480M | 9.6M | -$0.01 |
Guangdong VTR Bio-Tech Financials Summary
As of 30-Sep-2026, Guangdong VTR Bio-Tech has a trailing 12-month revenue of $120M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 348,482 | 381,000 | 367,345 | 360,161 |
| Revenue | 119,990 | 115,731 | 115,143 | 112,514 |
| EBITDA | (5,613) | 14,030 | 19,358 | 12,481 |
| Net Income | (4,974) | (2,750) | 4,333 | (1,519) |
| Total Assets | 420,619 | 418,046 | 403,911 | 436,607 |
| Total Debt | 7,558 | 8,878 | 4,811 | 18,092 |
Guangdong VTR Bio-Tech Patents
Guangdong VTR Bio-Tech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026158348-A1 | Nuclease mutant and use thereof | Pending | 22-Jan-2025 | ||
| WO-2026112760-A1 | Glucose oxidase mutant, preparation method therefor, and use thereof | Pending | 26-Nov-2024 | ||
| WO-2026091089-A1 | Acid protease mutant, encoding gene therefor, and use thereof | Pending | 01-Nov-2024 | ||
| WO-2026060548-A1 | Heat-resistant glucose oxidase mutant, preparation method therefor and use thereof | Pending | 18-Sep-2024 | ||
| WO-2026044477-A1 | Alkaline protease mutant and use thereof | Pending | 27-Aug-2024 |
Guangdong VTR Bio-Tech Signals
Guangdong VTR Bio-Tech Investments & Acquisitions (5)
Guangdong VTR Bio-Tech’s most recent deal was a Secondary Transaction - Private with Mekeda Bio-resources for . The deal was made on 05-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mekeda Bio-resources | 05-Jan-2024 | Secondary Transaction - Private | Other Agriculture | ||
| KYF (Pharmaceuticals) | 20-Sep-2019 | Secondary Transaction - Private | Pharmaceuticals | ||
| KYF (Pharmaceuticals) | 10-Dec-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Henan Lihua Pharmaceutical | 05-Aug-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Hunan Hongying Biotechnology | 29-Dec-2014 | Merger/Acquisition | Multi-line Chemicals |
Guangdong VTR Bio-Tech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Guangdong VTR Bio-Tech Exits (3)
Guangdong VTR Bio-Tech’s most recent exit was on 20-Sep-2019 from KYF (Pharmaceuticals). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| KYF (Pharmaceuticals) | 20-Sep-2019 | Completed |
|
||
| KYF (Pharmaceuticals) | 10-Dec-2015 | Completed |
|
||
| Henan Lihua Pharmaceutical | 05-Aug-2015 | Merger/Acquisition | Completed |
Guangdong VTR Bio-Tech Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mekeda Bio-resources | Liuyang, China | 2006 |
Guangdong VTR Bio-Tech FAQs
-
When was Guangdong VTR Bio-Tech founded?
Guangdong VTR Bio-Tech was founded in 1991.
-
Where is Guangdong VTR Bio-Tech headquartered?
Guangdong VTR Bio-Tech is headquartered in Zhuhai, China.
-
What is the size of Guangdong VTR Bio-Tech?
Guangdong VTR Bio-Tech has 1,106 total employees.
-
What industry is Guangdong VTR Bio-Tech in?
Guangdong VTR Bio-Tech’s primary industry is Biotechnology.
-
Is Guangdong VTR Bio-Tech a private or public company?
Guangdong VTR Bio-Tech is a Public company.
-
What is Guangdong VTR Bio-Tech’s stock symbol?
The ticker symbol for Guangdong VTR Bio-Tech is 300381.
-
What is the current stock price of Guangdong VTR Bio-Tech?
As of 13-Nov-2026 the stock price of Guangdong VTR Bio-Tech is $0.79.
-
What is the current market cap of Guangdong VTR Bio-Tech?
The current market capitalization of Guangdong VTR Bio-Tech is $377M.
-
What is Guangdong VTR Bio-Tech’s current revenue?
The trailing twelve month revenue for Guangdong VTR Bio-Tech is $120M.
-
What is Guangdong VTR Bio-Tech’s annual earnings per share (EPS)?
Guangdong VTR Bio-Tech’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process